![]() |
Interview: Med Ed 101: Dr. Eric Christianson...
December 1, 2014 - Featured , Professional Advice / Opinions By: Tasnima Nabi, Copy Editor [Content-Focused] – Social media is a powerful platform, allowing for the quick and easy exchange of ideas. Although the Internet has facilitated universal access, for many, it can be difficult to find reliable information. By combining the power of the Internet with his dedication to the pharmacy profession, Eric Christianson,… |
![]() |
Drug Shortages: Effects & Costs in the United Stat...
August 1, 2014 - Featured , Professional Advice / Opinions By: Valentina DiGangi,PharmD Candidate c/o 2017, Brandon Hu, PharmD Candidate c/o 2018, Sang Hyo Kim, Staff Editor, Samantha Lau, PharmD Candidate c/o 2018, and Seowoo Yoon, PharmD Candidate c/o 2018 – What does a clinician do when there is limited access to a particular drug, such as morphine? Should they treat a patient who is… |
![]() |
Grastek®: FDA Approves New Sublingual Immunotherapy fo...
July 1, 2014 - Featured , In the News / Politics By: Kevin Lin, PharmD Candidate c/o 2015 – This April, the FDA approved three sublingual immunotherapies for pollen induced allergic rhinitis: Grastek® (Timothy Grass Pollen Allergen Extract), Oralair® (Grass Pollen Allergen Extract), and Ragwitek® (Short Ragweed Pollen Allergen Extract). Formulated by Merck, Grastek® is Timothy grass pollen allergen extract. It is approved for patients ages… |
![]() |
The Status of Surveillance of Japanese Encephalitis in ...
March 1, 2014 - Featured , In the News / Politics By: Sabrina Ahmed, PharmD Candidate c/o 2017 – One recent stride towards combating worldwide infectious disease has been in the improved surveillance of Japanese encephalitis in Asia, predominantly in South and South-East Asia. This potentially deadly virus is transmitted to humans via mosquito bites. The Japanese encephalitis (JE) virus is the leading cause of encephalitis… |
![]() |
Long Term PPI Use Heightens Concern of Associated Healt...
February 1, 2014 - Clinical , Featured By: Tamara Yunusova, Senior Staff Editor – Proton Pump Inhibitors (PPIs) are acid-reducing agents that have multiple uses in the treatment and prophylaxis of conditions such as peptic ulcer diseases, H. Pylori infection, Zollinger-Ellison syndrome, GERD, and NSAID gastroduodenal ulcers. Their versatility in treating a wide range of conditions, unparalleled efficacy over their Histamine-2-receptor antagonist… |
![]() |
Dengue Fever: Where Do We Go From Here?...
February 1, 2014 - In the News / Politics By: Sherin Pathickal, PharmD Candidate c/o 2016 – Dengue Fever, widely known as “break-bone fever,” is an illness that causes pain in the joints and muscles, and is often described by those infected as comparable to the feeling of breaking a bone.1 It is spread by mosquitoes and has a painful array of symptomology such… |
![]() |
Pharmacy Across the Border: An Interview with Sherif Gu...
February 1, 2014 - Featured , Professional Advice / Opinions By: Sang Hyo Kim, Staff Editor – For the brand new year, we present an interview with Sherif Guorgui, the current Vice-President of Pharmacy at the Ontario Pharmacists Association and the former 2011-2012 President of the Ontario College of Pharmacists in Canada. Mr. Guorgui graduated in 1998 from the Faculty of Pharmacy at the University… |
![]() |
Hospital Drug Shortages...
December 1, 2013 - Featured , In the News / Politics By: Hamid Razaki, PharmD – Drug shortages seen across pharmacies in the United States continue to be an issue in patient care. A drug product shortage is defined as a supply issue that affects how the pharmacy prepares or dispenses a drug product, or that influences patient care when prescribers must use an alternative agent.1… |
![]() |
Meet the President: An Interview with Father Levesque...
December 1, 2013 - Featured , Professional Advice / Opinions By: Beatrice Popovitz, Staff Editor and Ada Seldin, Staff Editor – In August 2013, St. John’s University welcomed Rev. Joseph L. Levesque, C.M., former president of Niagara University, into the community as interim president. Fr. Levesque has an elaborate background in Vincentian leadership and higher education, having taught in various religious institutions such… |
![]() |
Zecuity(TM): Novel Treatment Option for Migraines...
November 1, 2013 - Clinical By: Arya Mathew, PharmD Candidate c/o 2014 – About twelve percent of the U.S. population suffers from migraines, affecting adult women three times more than adult men. Migraines are returning attacks of moderate to severe, throbbing or pulsing pain, usually on one side of the head. Along with the severe pain, migraine sufferers also experience… |
![]() |
Hope For Children with Acute Lymphoblastic Leukemia...
October 1, 2013 - Featured , In the News / Politics By: Ada Seldin, Staff Editor – Emily Whitehead, a 7-year-old girl who fought off relapsing acute lymphoblastic leukemia (ALL), has captured the hearts and prayers of the masses. Her story is an inspiration to those battling any disease with a poor prognosis and particularly holds promise for the 15% of children with ALL resistant to… |
![]() |
Children, Codeine, and Cytochrome P-450...
September 1, 2013 - Clinical , Featured By Davidta Brown, Staff Editor – For post-operative pain treatment, few drugs are as trustworthy, as tried-and-true, as codeine. Prescriptive confidence in the analgesic has promoted its use in children recovering from uncomplicated surgeries, but the spate of injuries and deaths of young children who had been given codeine after undergoing adenotonsillectomies has provoked a… |
![]() |
Drugs and Diseases: The Survival Manual...
August 1, 2013 - Professional Advice / Opinions By: Beatrisa Popovitz, Staff Editor – You may have heard the countless horror stories passed on by upperclassman of how D&Ds seep into the crevices of our brains and take over our psyches to inevitably make us breathe, sleep, and speak pharmacy. Stressing out over exams and investing what may seem like all of your… |
![]() |
Solving the HCV Enigma: Current and Future Drug Therapy...
July 1, 2013 - Clinical , Featured By: Tamara Yunusova, Senior Staff Editor – Approximately 3.2 million Americans have chronic hepatitis C infection.1 While acute cases are not common, rates of chronic hepatitis C continue to surge due to the recent discovery of the virus in 1989 and consequently, the establishment of a test screening for HCV antibodies in 1992.1 HCV has… |
![]() |
Lower Vaccine Costs for Developing Nations...
July 1, 2013 - Featured , In the News / Politics By: Steve Soman, PharmD – India has become a powerhouse in pharmaceutical manufacturing, often supplying generic alternatives at a fraction of the brand name cost to the developing world. Cheaper alternatives make costly drugs more affordable for poorer nations and NGOs.1 Indian manufacturer Biological E. Limited, a biotech firm based in Hyderabad India, signed a… |
![]() |
Coffeehouse Chats...
June 1, 2013 - Events By: Ada Seldin and Moisey Rafailov, PharmD Candidates Class of 2015 – The “Coffeehouse Chats” is an annual Rho Chi Society Event that serves as a steppingstone to fostering professional relationships between students and faculty. The event provides a platform for students and professors to exchange experiences and ideas. This year, the event took place… |
![]() |
FDA Approves Dimethyl Fumarate for Treatment of Relapsi...
June 1, 2013 - Clinical , Featured By: Andy Zhang, PharmD Candidate c/o 2015 – On March 28, 2013, the U.S. Food and Drug Administration announced the approval of Tecfidera™ (dimethyl fumarate) for the treatment of relapsing forms of multiple sclerosis (MS) in adults.1 Tecfidera™ (dimethyl fumarate) will be the third oral drug used for the treatment of MS. The manufacturer Biogen… |
![]() |
The Opioid Debate: PROP and PROMPT Battle Away...
January 1, 2013 - Featured , In the News / Politics By: Tamara Yunusova – On Wednesday, July 25th a petition signed by the reform group Physicians for Responsible Opioid Prescribing (PROP) called on the FDA to implement opioid label changes that would restrict Chronic Non-Cancer (CNCP) opioid treatment for patients with severe pain only. It wasn’t too long before another petition signed by PROP’s adversary,… |
![]() |
Tackling America’s Drug Shortage Crisis...
December 1, 2012 - Featured , In the News / Politics , Professional Advice / Opinions By: John S Lim, PharmD Candidate c/o 2013 – America’s focus on healthcare, as well as its position as one of the wealthiest nations of the industrialized world, is incongruous with the consequences of drug shortages suffered by its population. Shortages in pharmaceutical supply compromise quality of life while increasing health care costs. The pharmaceutical… |
![]() |
Giving a Second Chance: The Prescription Drug Abuse Epi...
December 1, 2012 - Featured , In the News / Politics , Professional Advice / Opinions By: Maria Sorbera, PharmD Candidate c/o 2013 at AMSCOP (LIU) – Author William S. Burroughs states in his novel, “The question is frequently asked: Why does a man become a drug addict? The answer is that he usually does not intend to become an addict. You don’t wake up one morning and decide to be… |
![]() |
Safety and Efficacy of Atropine for Salivary Hypersecre...
November 1, 2012 - Clinical By: Elsa Thomas, PharmD Candidate c/o 2013 – Atropine is an anticholinergic used to treat various conditions, such as bradycardia, neuromuscular blockade, mydriasis, nerve agent poisoning, and salivary hypersecretion.1,2 Pharmacologically, it inhibits smooth muscle and glands innervated by postganglionic cholinergic nerves.1,2 It also has functions in the central nervous system (CNS); it could stimulate or… |
![]() |
SSRI Discontinuation Syndrome...
November 1, 2012 - Clinical By: Shannon Tellier, PharmD Candidate c/o 2013 – Antidepressant discontinuation syndrome has been reported in all categories of antidepressants after an abrupt interruption of therapy.1 Symptoms usually occur within a few days of stopping or reducing the dosage of the antidepressant, and rarely occur with therapy of less than five weeks.1 If left untreated, most… |
![]() |
My Experiences at NewYork-Presbyterian Hospital...
October 1, 2012 - Professional Advice / Opinions By: Addolorata Ciccone, Student Copy Editor – As a fifth-year pharmacy student researching and ranking advanced pharmacy practice experience (APPE) sites, I felt excited at the prospect of taking the knowledge and skills I obtained in the classroom and applying it to real world patients and scenarios. My years of work in community pharmacies were… |
![]() |
Brand Vs. Generic: What Every Prescriber Should Know...
September 1, 2012 - Clinical , Featured , Professional Advice / Opinions By: Marina Yermolayeva, PharmD Candidate c/o 2013 – “I’m allergic to the generic; I need the brand name medication,” is a common claim heard by many health care providers. Managed care organizations get numerous calls from doctors and patients requesting prior authorizations to approve brand name medications whilst there are generic alternatives available on formulary.… |
![]() |
Rho Chi Executive Board Member Insight: Elizabeth Mo...
August 1, 2012 - Professional Advice / Opinions By: Mohammad A. Rattu, Pharm.D. [PGY-1 Resident at VA NYHHS] – We sometimes need to step back and look at our foundations for success. Without the support of past and present Rho Chi executive boards, there would be no Rho Chi Post newsletter. From our May to September issues, we will learn about each of… |
![]() |
Understanding Diabetic Ketoacidosis...
July 1, 2012 - Clinical , Featured By: Mohamed Dungersi, Associate Student Editor – What is diabetic ketoacidosis (DKA)? Diabetic ketoacidosis (DKA) is an acute complication of uncontrolled diabetes or hyperglycemia. It is usually observed in cases of extreme hyperglycemia (usually in excess of 500 mg/dl, though it can occur over 250 mg/dl).1,2 It is usually characterized by the presence of hyperglycemia,… |
![]() |
Five Lessons Learned from Being an Assistant Dean...
June 1, 2012 - Featured , Professional Advice / Opinions By: Laura Gianni Augusto, B.S., Pharm.D., Associate Clinical Professor, Department of Clinical Pharmacy Practice – Laura Gianni Augusto, Pharm.D., R.Ph. is an Associate Clinical Professor in the Department of Clinical Pharmacy Practice at St. John’s University College of Pharmacy and Health Sciences. She served as Assistant Dean for Experiential Pharmacy Education from 2007 to 2011.… |
![]() |
A Reflection of my Palliative Care Rotation...
June 1, 2012 - Professional Advice / Opinions By: Stanley Saji, Pharm.D. Candidate c/o 2013 – I had a preconceived notion that advanced pharmacy practice experiences (APPEs) were just an application of concepts and therapies learned in pharmacy school. Little did I know how real APPEs became… During my third rotation, I worked with Dr. Maha Saad, Assistant Clinical Professor in the Department… |
![]() |
The End of an Era...
June 1, 2012 - Professional Advice / Opinions By: Pooja Patel, Pharm.D. Candidate c/o 2013 – The ‘end of an era’ is a fitting way to describe my rotation this past February with Dr. Gladys El-Chaar at Steven and Alexandra Cohen’s Children’s Medical Center of New York. As many have heard, Dr. El-Chaar shifted from her long-standing position at Long Island Jewish Medical… |
![]() |
My Pharmacy Journey...
June 1, 2012 - Professional Advice / Opinions By: Jena Marion, Pharm.D. Candidate c/o 2013 – I have traveled a lot these past few years. I have packed and unpacked suitcases, measured three-ounce bottles of liquids, and printed plenty of boarding passes. Most of my trips were for business, but a few were for pleasure. Pharmacy, however, followed me along on each one… |
![]() |
Naloxone Distribution Programs...
June 1, 2012 - Clinical , Featured , In the News / Politics By: Mahdieh Danesh Yazdi, Associate Student Editor, with Special Thanks to Dr. Tomasz Jodlowski for his contributions to this article – In the 1990s, major urban and rural areas across the United States grappled with a common problem: drug addiction. At that time, the drugs of choice were illicit substances (i.e. heroin). In order to combat… |
![]() |
Proton Pump Inhibitor Use and Complications...
June 1, 2012 - Clinical By: Lauren Kaveski, Pharm.D. Candidate c/o 2013 – We see proton pump inhibitors (PPIs) used in many medication regimens, but it is unknown whether the majority of patients receive these medications for appropriate durations or indications. For all labeled indications, other than Zollinger-Ellison Syndrome (a rare condition characterized by damaging gastrin hypersecretion and subsequent hydrochloric… |
![]() |
Professor of the Year: Dr. Maidhof...
May 1, 2012 - Featured , Professional Advice / Opinions By: Mohamed Dungersi, Associate Student Editor – Dr. William Maidhof is an Assistant Professor and Industry Professional in the Clinical Pharmacy Practice department of the St. John’s University College of Pharmacy and Allied Health Professions. He is an alumnus of St. John’s University who graduated in 1999 with a BS in Pharmacy and again in… |
![]() |
Student Pharmacist Star of the Month: Michelle Pernice...
April 1, 2012 - Professional Advice / Opinions By: Marie Huang – Each month, the Rho Chi Post has the wonderful opportunity to sit down with an inspiring leader among the student pharmacists here at St. John’s University College of Pharmacy and Allied Health Professions – someone who is not afraid to stand apart from the crowd and can be the change he… |
![]() |
Featured Organization: Urban Santa Project (USP)...
April 1, 2012 - Professional Advice / Opinions By: Sibyl Cherian, PharmD Candidate c/o 2013 – Santhosh Cherian, is the co-founder and executive director of the Urban Humanitarian Projects (UHP). He is currently in his third year of medical school at St. George University and is completing his clinical clerkships in Brooklyn, New York. St. John’s University is a Catholic, Vincentian and metropolitan… |
![]() |
Faculty Spotlight: Dr. Hira Shafeeq...
April 1, 2012 - Featured , Professional Advice / Opinions By: Jessica Lee, Pharm.D. Candidate c/o 2013 – Dr. Hira Shafeeq received her PharmD in 2009 from St. John’s University. After graduating, she went on to do her PGY-1 at the Brooklyn Hospital Center. Upon finishing her first year of residency, she decided to complete her specialty residency in critical care at University of Chicago… |
![]() |
Drug Shortage Update: FDA Successfully Alleviates Chemo...
March 1, 2012 - In the News / Politics By: Mahdieh Danesh Yazdi – As previously reported, there is currently great concern in the medical community because of the growing number of drug shortages. Many of these are drugs that are critical to patient care, such as chemotherapy agents and antibiotics. Last October, President Obama issued an executive order in an attempt to curb… |
![]() |
Student Pharmacist Star of the Month: Praneeta Nagraj...
March 1, 2012 - Professional Advice / Opinions By: Marie Huang – Each month, the Rho Chi Post has the wonderful opportunity to sit down with an inspiring leader among the student pharmacists here at St. John’s University College of Pharmacy and Allied Health Professions – someone who is not afraid to stand apart from the crowd and can be the change he… |
![]() |
Link Revealed: PPI Usage, Smoking and Bone Fractures...
February 1, 2012 - Clinical , In the News / Politics By: Ebey P. Soman – Proton pump inhibitors (PPIs) are medications commonly prescribed to treat heartburn, acid reflux disease, and ulcers. Almost a vast majority of patients in the United States seem to be taking a PPI, either as a prescription or from over-the-counter (OTC). Researchers recently discovered associations between the long-term use of PPIs… |
![]() |
Liposomal Doxorubicin For Liver Cancer...
January 1, 2012 - Clinical By Lunbao (Jerry) Huang, Pharm.D. Candidate c/o 2013 – Over the last two decades, there has been an increasing focus on hepatocellular carcinoma (HCC, most commonly known as liver cancer). In the United States, as of 2011, there have been an estimated 26,190 new cases and 19,590 deaths from both hepatic and intrahepatic bile duct cancer. Defined by the… |
![]() |
Placement of Carisoprodol into Schedule IV...
January 1, 2012 - In the News / Politics By Jena Marion, Pharm.D. Candidate c/o 2013 – On December 12, 2011, the Administrator of the Drug Enforcement Agency (DEA) ruled to place carisoprodol (Soma®) into Schedule IV of the Controlled Substances Act (CSA). Carisoprodol has been in use since it was approved for marketing in the U.S. in 1959 with the indication of “relief… |
![]() |
Clevidipine in the Management of Hypertensive Emergency...
January 1, 2012 - Clinical , Featured By: Neal Shah – Defined by the Joint National Committee, hypertension (HTN) is a systolic blood pressure (SBP) greater than or equal to 140 mmHg and a diastolic blood pressure (DBP) greater than or equal to 90 mmHg. Patients with Stage 1 HTN have a SBP between 140 and 159 mmHg and DBP between 90… |
![]() |
Differences Between Antagonists and Inverse Agonists...
December 1, 2011 - Clinical By: Neal Shah – There are two major classifications of drug-receptor activity: agonism and antagonism. Agonism occurs when a molecule binds to a receptor, causes an exertion of normal receptor operation, and eventually causes a response. Antagonism of a receptor occurs when a molecule binds to the receptor and does not allow activity to occur.1… |
![]() |
Drug Shortages: Impacts and Prevention Measures...
December 1, 2011 - Featured , In the News / Politics , Professional Advice / Opinions By: Jimmy Johnson, PharmD Candidate c/o 2012 – Drug shortages have become more and more of an issue in the health care industry. There are over 200 drugs on the Food and Drug Administration’s (FDA) drug shortage list – a number that has tripled in the last five years.1 The largest impact has been on anesthesia… |
![]() |
Federal Government to Attempt Limiting Drug Shortages...
December 1, 2011 - In the News / Politics By: Mahdieh Danesh Yazdi, with special thanks to Dr. Tomasz Jodlowski – Drug shortages have plagued health care institutions in recent years; they present a serious problem to health care delivery on a national scale. In 2004, there were 58 drug shortages; now, in 2011, this number has increased to 198. Due to limited access… |
![]() |
It’s Time to Get Involved!...
November 1, 2011 - Professional Advice / Opinions By: Khilna Patel, PharmD Candidate c/o 2012 – Top academic achievement is a plus but is not the only thing to strive for – college is about developing one‘s self as a whole. There are many opportunities to get involved. Don‘t be afraid to try everything that may interest you because it will only bring… |
![]() |
SpongeBob SquarePants… Harmful?...
November 1, 2011 - Clinical , Featured By: Ebey P. Soman – Current research demonstrates a strong correlation between the length of time a child watches television and decreased long-term attention deficiency disorders. A new study by Lillard and Peterson at the Department of Psychology at the University of Virginia suggests that the popular children‘s television show, SpongeBob SquarePants, might be harmful.… |
![]() |
Event Spotlight: Mock Residency Interviews...
November 1, 2011 - Events By: Neal Shah – As the year comes to a close, many pharmacy students are turning their sights onto the process of residency interviews. Residencies provide a competitive edge and an educational fulfillment to future pharmacists who wish to engage in clinical practice. On October 26th, Rho Chi held its first Mock Residency Interviews, open… |
![]() |
Speaker Spotlight: A Dose of Reality With Laura Cransto...
October 1, 2011 - Events By: Ebey P. Soman – During a seminar held by the Career Center on September 30th, 2011, I had the opportunity to hear Mrs. Laura Cranston. She is a pharmacy graduate of St. John‟s University (class of 1984) and a former Executive Resident of the American Society of Consultant Pharmacists (ASCP). Dr. Robert Mangione, Dean… |